Literature DB >> 11368110

Kaposi's sarcoma before and during a human immunodeficiency virus epidemic in Tanzanian children.

H Amir1, E E Kaaya, K P Manji, G Kwesigabo, P Biberfeld.   

Abstract

BACKGROUND: With the onset of AIDS increased frequency of Kaposi's sarcoma (KS) has been reported. However, there is no case-based comparison of childhood (<14 years) KS before and during the HIV pandemic in sub-Saharan Africa. Here we report on the Tanzanian cancer registry data of pediatric KS in Tanzania and implications with regard to pathogenic factors.
METHODS: One hundred fifty histologically confirmed pediatric KS (PKS) cases registered during 1968 through 1995 (28 years) were analyzed with regard to demographic and clinical characteristics before and during the AIDS epidemic. Statistical analysis was done with the Epi-Info program and chi square test.
RESULTS: Of children with PKS 126 (84%) were male and 24 (16%) were female. The gender ratio was 5.1:1 and 5.4:1 during the endemic and epidemic periods, respectively. The highest occurrence of PKS was observed in the 0- to 5-years age group. Overall 73 (4.9/year) of these cases were registered during the pre and 77 (5.9/year) during the AIDS period. Over time a significant increase in anatomically disseminated KS cases was evident during the AIDS epidemic (P = 0.003).
CONCLUSIONS: These observations indicate that children younger than 5 years are at high risk for developing KS, possibly reflecting low resistance to human herpesvirus (HHV) 8 infection. It is also likely that an increased susceptibility to HHV8 infection and morbidity is related to progressive immunodeficiency. The increase in AIDS PKS incidence appears to reflect a direct or indirect promoting effect of HIV on the development of KS lesions. Recognition of the high KS risk in small children warrants considerations of possible prevention measures including HIV/HHV8 vaccination and therapeutic options.

Entities:  

Mesh:

Year:  2001        PMID: 11368110     DOI: 10.1097/00006454-200105000-00009

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  15 in total

1.  Kaposi's sarcoma: a 10-year experience with 248 patients at a single tertiary care hospital in Tanzania.

Authors:  Phillipo L Chalya; Fidelis Mbunda; Peter F Rambau; Hyasinta Jaka; Nestory Masalu; Mariam Mirambo; Martha F Mushi; Samuel E Kalluvya
Journal:  BMC Res Notes       Date:  2015-09-15

2.  Childhood cancer: an emerging public health issue in China.

Authors:  Lingeng Lu; Chan Huang; Huatian Huang
Journal:  Ann Transl Med       Date:  2015-10

Review 3.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

4.  Impact of infection with human immunodeficiency virus-1 (HIV) on the risk of cancer among children in Malawi - preliminary findings.

Authors:  Nora Mutalima; Elizabeth M Molyneux; William T Johnston; Harold W Jaffe; Steve Kamiza; Eric Borgstein; Nyengo Mkandawire; George N Liomba; Mkume Batumba; Lucy M Carpenter; Robert Newton
Journal:  Infect Agent Cancer       Date:  2010-02-12       Impact factor: 2.965

5.  Pulmonary Kaposi sarcoma in six children.

Authors:  Salomine Theron; Savvas Andronikou; Jaco Du Plessis; Pierre Goussard; Reena George; Ayanda Mapukata; Marie Grobbelaar; Murray Hayes; Nicky Wieselthaler; Alan Davidson
Journal:  Pediatr Radiol       Date:  2007-10-17

6.  Binding of the Kaposi's sarcoma-associated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule.

Authors:  Alexander S Hahn; Ronald C Desrosiers
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

7.  KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development.

Authors:  Pawan Pyakurel; Fatemeh Pak; Amos R Mwakigonja; Ephata Kaaya; Peter Biberfeld
Journal:  Infect Agent Cancer       Date:  2007-02-02       Impact factor: 2.965

8.  Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions.

Authors:  Amos R Mwakigonja; Pawan Pyakurel; Parviz Kokhaei; Fatemeh Pak; Leonard K Lema; Ephata E Kaaya; Peter Biberfeld
Journal:  Infect Agent Cancer       Date:  2008-06-30       Impact factor: 2.965

9.  Children with kaposi sarcoma in two southern african hospitals: clinical presentation, management, and outcome.

Authors:  G P De Bruin; D C Stefan
Journal:  J Trop Med       Date:  2013-12-11

Review 10.  Kaposi sarcoma in unusual locations.

Authors:  Liron Pantanowitz; Bruce J Dezube
Journal:  BMC Cancer       Date:  2008-07-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.